Global Gastroesophageal Reflux Disease Therapeutics Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gastroesophageal Reflux Disease Therapeutics Market Size 2017-2028

2.1.2 Gastroesophageal Reflux Disease Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Gastroesophageal Reflux Disease Therapeutics Segment by Type

2.2.1 Antacids

2.2.2 H2 Receptor Blockers

2.2.3 Proton Pump Inhibitors (PPIs)

2.2.4 Pro-kinetic Agents

2.2.5 Others

2.3 Gastroesophageal Reflux Disease Therapeutics Market Size by Type

2.3.1 Gastroesophageal Reflux Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Gastroesophageal Reflux Disease Therapeutics Segment by Application

2.4.1 Hospital Pharmacy

2.4.2 Drug Stores

2.4.3 General Stores

2.4.4 Supermarkets

2.5 Gastroesophageal Reflux Disease Therapeutics Market Size by Application

2.5.1 Gastroesophageal Reflux Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application (2017-2022)

3 Gastroesophageal Reflux Disease Therapeutics Market Size by Player

3.1 Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Players

3.1.1 Global Gastroesophageal Reflux Disease Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Gastroesophageal Reflux Disease Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Gastroesophageal Reflux Disease Therapeutics by Regions

4.1 Gastroesophageal Reflux Disease Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Gastroesophageal Reflux Disease Therapeutics Market Size Growth (2017-2022)

4.3 APAC Gastroesophageal Reflux Disease Therapeutics Market Size Growth (2017-2022)

4.4 Europe Gastroesophageal Reflux Disease Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2017-2022)

5.2 Americas Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022)

5.3 Americas Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2017-2022)

6.2 APAC Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022)

6.3 APAC Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Gastroesophageal Reflux Disease Therapeutics by Country (2017-2022)

7.2 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022)

7.3 Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.1 Global Gastroesophageal Reflux Disease Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Gastroesophageal Reflux Disease Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Gastroesophageal Reflux Disease Therapeutics Forecast

10.1.3 APAC Gastroesophageal Reflux Disease Therapeutics Forecast

10.1.4 Europe Gastroesophageal Reflux Disease Therapeutics Forecast

10.1.5 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Forecast

10.2 Americas Gastroesophageal Reflux Disease Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.2.2 Canada Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.2.3 Mexico Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.2.4 Brazil Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.3 APAC Gastroesophageal Reflux Disease Therapeutics Forecast by Region (2023-2028)

10.3.1 China Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.3.2 Japan Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.3.3 Korea Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.3.4 Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.3.5 India Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.3.6 Australia Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.4 Europe Gastroesophageal Reflux Disease Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.4.2 France Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.4.3 UK Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.4.4 Italy Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.4.5 Russia Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.5 Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.5.2 South Africa Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.5.3 Israel Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.5.4 Turkey Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.5.5 GCC Countries Gastroesophageal Reflux Disease Therapeutics Market Forecast

10.6 Global Gastroesophageal Reflux Disease Therapeutics Forecast by Type (2023-2028)

10.7 Global Gastroesophageal Reflux Disease Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 AstraZeneca

11.1.1 AstraZeneca Company Information

11.1.2 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Product Offered

11.1.3 AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 AstraZeneca Main Business Overview

11.1.5 AstraZeneca Latest Developments

11.2 Eisai

11.2.1 Eisai Company Information

11.2.2 Eisai Gastroesophageal Reflux Disease Therapeutics Product Offered

11.2.3 Eisai Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Eisai Main Business Overview

11.2.5 Eisai Latest Developments

11.3 Takeda Pharmaceutical

11.3.1 Takeda Pharmaceutical Company Information

11.3.2 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Offered

11.3.3 Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Takeda Pharmaceutical Main Business Overview

11.3.5 Takeda Pharmaceutical Latest Developments

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Information

11.4.2 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Product Offered

11.4.3 GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 GlaxoSmithKline Main Business Overview

11.4.5 GlaxoSmithKline Latest Developments

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Information

11.5.2 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Product Offered

11.5.3 Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Johnson & Johnson Main Business Overview

11.5.5 Johnson & Johnson Latest Developments

11.6 Daewoong Pharmaceutical

11.6.1 Daewoong Pharmaceutical Company Information

11.6.2 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Offered

11.6.3 Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Daewoong Pharmaceutical Main Business Overview

11.6.5 Daewoong Pharmaceutical Latest Developments

11.7 Ironwood Pharmaceuticals

11.7.1 Ironwood Pharmaceuticals Company Information

11.7.2 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product Offered

11.7.3 Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Ironwood Pharmaceuticals Main Business Overview

11.7.5 Ironwood Pharmaceuticals Latest Developments

12 Research Findings and Conclusion

Table 1. Gastroesophageal Reflux Disease Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Antacids

Table 3. Major Players of H2 Receptor Blockers

Table 4. Major Players of Proton Pump Inhibitors (PPIs)

Table 5. Major Players of Pro-kinetic Agents

Table 6. Major Players of Others

Table 7. Gastroesophageal Reflux Disease Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 10. Gastroesophageal Reflux Disease Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 13. Global Gastroesophageal Reflux Disease Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Player (2020-2022)

Table 15. Gastroesophageal Reflux Disease Therapeutics Key Players Head office and Products Offered

Table 16. Gastroesophageal Reflux Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Gastroesophageal Reflux Disease Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Regions (2017-2022)

Table 21. Americas Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Country (2017-2022)

Table 23. Americas Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 25. Americas Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 27. APAC Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Region (2017-2022)

Table 29. APAC Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 31. APAC Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 33. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Country (2017-2022)

Table 35. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 37. Europe Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Gastroesophageal Reflux Disease Therapeutics

Table 46. Key Market Challenges & Risks of Gastroesophageal Reflux Disease Therapeutics

Table 47. Key Industry Trends of Gastroesophageal Reflux Disease Therapeutics

Table 48. Global Gastroesophageal Reflux Disease Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Gastroesophageal Reflux Disease Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Gastroesophageal Reflux Disease Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 54. AstraZeneca Details, Company Type, Gastroesophageal Reflux Disease Therapeutics Area Served and Its Competitors

Table 55. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Product Offered

Table 56. AstraZeneca Gastroesophageal Reflux Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. AstraZeneca Main Business

Table 58. AstraZeneca Latest Developments

Table 59. Eisai Details, Company Type, Gastroesophageal Reflux Disease Therapeutics Area Served and Its Competitors

Table 60. Eisai Gastroesophageal Reflux Disease Therapeutics Product Offered

Table 61. Eisai Main Business

Table 62. Eisai Gastroesophageal Reflux Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Eisai Latest Developments

Table 64. Takeda Pharmaceutical Details, Company Type, Gastroesophageal Reflux Disease Therapeutics Area Served and Its Competitors

Table 65. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Offered

Table 66. Takeda Pharmaceutical Main Business

Table 67. Takeda Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Takeda Pharmaceutical Latest Developments

Table 69. GlaxoSmithKline Details, Company Type, Gastroesophageal Reflux Disease Therapeutics Area Served and Its Competitors

Table 70. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Product Offered

Table 71. GlaxoSmithKline Main Business

Table 72. GlaxoSmithKline Gastroesophageal Reflux Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. GlaxoSmithKline Latest Developments

Table 74. Johnson & Johnson Details, Company Type, Gastroesophageal Reflux Disease Therapeutics Area Served and Its Competitors

Table 75. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Product Offered

Table 76. Johnson & Johnson Main Business

Table 77. Johnson & Johnson Gastroesophageal Reflux Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Johnson & Johnson Latest Developments

Table 79. Daewoong Pharmaceutical Details, Company Type, Gastroesophageal Reflux Disease Therapeutics Area Served and Its Competitors

Table 80. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Product Offered

Table 81. Daewoong Pharmaceutical Main Business

Table 82. Daewoong Pharmaceutical Gastroesophageal Reflux Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Daewoong Pharmaceutical Latest Developments

Table 84. Ironwood Pharmaceuticals Details, Company Type, Gastroesophageal Reflux Disease Therapeutics Area Served and Its Competitors

Table 85. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Product Offered

Table 86. Ironwood Pharmaceuticals Main Business

Table 87. Ironwood Pharmaceuticals Gastroesophageal Reflux Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Ironwood Pharmaceuticals Latest Developments

List of Figures

Figure 1. Gastroesophageal Reflux Disease Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Gastroesophageal Reflux Disease Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Type in 2021

Figure 7. Gastroesophageal Reflux Disease Therapeutics in Hospital Pharmacy

Figure 8. Global Gastroesophageal Reflux Disease Therapeutics Market: Hospital Pharmacy (2017-2022) & ($ Millions)

Figure 9. Gastroesophageal Reflux Disease Therapeutics in Drug Stores

Figure 10. Global Gastroesophageal Reflux Disease Therapeutics Market: Drug Stores (2017-2022) & ($ Millions)

Figure 11. Gastroesophageal Reflux Disease Therapeutics in General Stores

Figure 12. Global Gastroesophageal Reflux Disease Therapeutics Market: General Stores (2017-2022) & ($ Millions)

Figure 13. Gastroesophageal Reflux Disease Therapeutics in Supermarkets

Figure 14. Global Gastroesophageal Reflux Disease Therapeutics Market: Supermarkets (2017-2022) & ($ Millions)

Figure 15. Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application in 2021

Figure 16. Global Gastroesophageal Reflux Disease Therapeutics Revenue Market Share by Player in 2021

Figure 17. Global Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Gastroesophageal Reflux Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. APAC Gastroesophageal Reflux Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Europe Gastroesophageal Reflux Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size 2017-2022 ($ Millions)

Figure 22. Americas Gastroesophageal Reflux Disease Therapeutics Value Market Share by Country in 2021

Figure 23. Americas Gastroesophageal Reflux Disease Therapeutics Consumption Market Share by Type in 2021

Figure 24. Americas Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application in 2021

Figure 25. United States Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Region in 2021

Figure 30. APAC Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application in 2021

Figure 31. China Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Country in 2021

Figure 38. Europe Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Type in 2021

Figure 39. Europe Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application in 2021

Figure 40. Germany Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size Market Share by Application in 2021

Figure 48. Egypt Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Gastroesophageal Reflux Disease Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. APAC Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. Europe Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. United States Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Canada Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. China Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Japan Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. Korea Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. India Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. Australia Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. Germany Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. France Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. UK Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Italy Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Russia Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. Spain Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. Israel Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Gastroesophageal Reflux Disease Therapeutics Market Size 2023-2028 ($ Millions)